Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Alex Z Fu"'
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0188812 (2017)
The past decade has witnessed adoption of conservative gynecologic treatments, including minimally invasive surgery (MIS), alongside steady declines in inpatient hysterectomies. It remains unclear what factors have contributed to trends in outpatient
Externí odkaz:
https://doaj.org/article/0104a1cf7c4a46f180e57e575fd62306
Autor:
Doris K. Hansen, Santosh Gautam, Marie‐Hélène Lafeuille, Carmine Rossi, Bronwyn Moore, Anabelle Tardif‐Samson, Philippe Thompson‐Leduc, Alex Z. Fu, Annelore Cortoos, Shuchita Kaila, Rafael Fonseca
Publikováno v:
Cancer Medicine, Vol 13, Iss 21, Pp n/a-n/a (2024)
ABSTRACT Introduction Daratumumab, lenalidomide, and dexamethasone (DRd) and bortezomib, lenalidomide, and dexamethasone (VRd) are the only preferred treatment regimens for patients with transplant‐ineligible (TIE) newly diagnosed multiple myeloma
Externí odkaz:
https://doaj.org/article/801902035fdd43bb97b917d0bf035504
Autor:
Qun Wang, Alex Z Fu, Stephan Brenner, Olivier Kalmus, Hastings Thomas Banda, Manuela De Allegri
Publikováno v:
PLoS ONE, Vol 10, Iss 1, p e0116897 (2015)
In Sub-Saharan Africa (SSA) the disease burden of chronic non-communicable diseases (CNCDs) is rising considerably. Given weaknesses in existing financial arrangements across SSA, expenditure on CNCDs is often borne directly by patients through out-o
Externí odkaz:
https://doaj.org/article/007145d66f4344ba83092dd586fc6776
Autor:
Rafael Fonseca, MD, Eric E. Chinaeke, PhD, Niodita Gupta-Werner, MD, MPH, PhD, Alex Z. Fu, PhD, Shuchita Kaila, PhD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 7, Iss 5, Pp 430-436 (2023)
Daratumumab (DARA) is an anti-CD38 monoclonal antibody approved as a combination therapy for newly diagnosed multiple myeloma (MM) and as monotherapy and combination therapy for relapsed or refractory MM cases. We assessed the length of DARA use acro
Externí odkaz:
https://doaj.org/article/781b01703aba40e4a235589cc80f3aeb
Autor:
Aarti A. Patel, Shannon Allen Ferrante, Iris Lin, Alex Z. Fu, Alicia K. Campbell, Arlene Tieng
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 5, Pp 1241-1253 (2023)
Abstract Introduction In patients with psoriatic arthritis (PsA), potential differences in care by race/ethnicity have not been well studied. Methods This retrospective, observational cohort analysis utilized the IBM MarketScan® Multi-State Medicaid
Externí odkaz:
https://doaj.org/article/70b0418768194b78b2e04eb502b5dd4e
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Inflammatory bowel disease (IBD) is a chronic disease with the potential for significant morbidity in case of suboptimal treatment (e.g. low treatment adherence). In spite of immense research in IBD, literature on association of I
Externí odkaz:
https://doaj.org/article/fdad2ad574ca4ddc82b5e321521b6532
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background There is limited real-world evidence that describes patients with newly diagnosed multiple myeloma (NDMM) treated with the bortezomib, lenalidomide, and dexamethasone (VRd) triplet regimen. We evaluated patient characteristics and
Externí odkaz:
https://doaj.org/article/c8ee0a4c00164db59f7c5cbd65e0bd7d
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Long-acting injectable (LAI) antipsychotics use is associated with improved adherence which can reduce the rate of relapse, hospitalization, and associated costs in patients with schizophrenia. Young adults could be at higher risk
Externí odkaz:
https://doaj.org/article/b442ec474d8c457a8d1a298f42d453f0
Publikováno v:
BMC Rheumatology, Vol 6, Iss 1, Pp 1-10 (2022)
Abstract Background Social determinants of health (SDH), including food insecurity, are associated with depression in the general population. This study estimated the prevalence of depression and food insecurity and evaluated the impact of food insec
Externí odkaz:
https://doaj.org/article/aa28c2b5c7b448d5bded3b33795230d1
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:293-302
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a996ab50527dfb5f48fa9d52622c407
https://doi.org/10.18553/jmcp.2023.22191
https://doi.org/10.18553/jmcp.2023.22191